Researchers at the UAB have carried out two revealing studies on TRPV2, a key ion channel in several cellular functions, which points to it as a possible new therapeutic target in the treatment of hypertension....
Anticoagulants are drugs used in people at high risk of blood clots to reduce their risk. This study, which has the collaboration of the UAB, has compared the risk of suffering a stroke or pulmonary embolism, pneumonia, being admitted to hospital,...
.jpg)
A study published in the Journal of Medicinal Chemistry by the Neuroscience Institute researchers Óscar Díaz, James Dalton and Jesús Giraldo, describes the potential activation mechanism of cannabinoid receptor 1 (CB1)....
Antibiotic resistance is nowadays one of the most serious threats to global health; a challenge considered to even rival Climate Change....
Selective drug delivery (nanoconjugates generated by the cell-targeted drug and a nanoscale vehicle) could be a great asset in cancer treatment. Due to biosafety problems of the nanomaterials studied so far, emerging nanobiotechnologies are pushing the development of fully...
Synchrotron light has been used for the first time to simulate damages due to oxidative stress on the aldose reductase protein with the aim of obtaining its activated form. This form of the protein, related with some...
Most serious and fatal adverse effects are caused by well-known and commonly prescribed medicines, and have a great public health impact. This article reflects on what use is given to these drugs and considers what strategies could be used to avoid the adverse reactions,...
Nowadays, biomarkers to detect water contaminants coming from human pharmaceuticals are much needed to prevent deterioration of the aquatic environment. In this study, the effects of Gemfibrozil, a pharmaceutical widely found in the aquatic environment, were...
A new study by the Immunology of Diabetes Group, led by Marta Vives-Pi at the IGTP-UAB in collaboration with the University Hamburg-Eppendorf, looks into the effect of betamethasone on new-borns and its...
Fernando Rodríguez de Fonseca (IBIMA Institute - Regional University Hospital of Malaga) gave a seminar at the UAB Institut de Neurociències (INC)...
